AVILA
LIVE

Serial Number

98797469

Owner

Avila Science, Inc.

Attorney

Mark A. Jansen

Filing Date

Oct 11, 2024

Add to watchlist:

No watchlists yet
View on USPTO

AVILA Trademark

Serial Number: 98797469

AVILA is a trademark filed by Avila Science, Inc. on October 11, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently pending registration.

Owner Contact Info

Avila Science, Inc. (2 trademarks)

114 Crosby Street, 7th Floor
New York, NY 10012

Entity Type: 03

Trademark Details

Filing Date

October 11, 2024

Registration Date

Not Registered

Goods & Services

Healthcare services, namely, providing medical treatment in the fields of early pregnancy loss, miscarriage, infertility, and pregnancy complications; Healthcare services, namely, a patient access program providing pharmaceuticals for pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing medical information in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Medical services; Pharmaceutical compounding services; Medical advisory services; Medical consultation and counseling services in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Medical consultations and therapy provided via website, phone, online chat or videoconferencing; Telemedicine services in the field of pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Women's health care and wellness services, namely, providing online information related to health care and wellness services; Preparation and dispensing of medications

Pharmaceutical and medical preparations; Pharmaceuticals for the management of early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications

Downloadable software; Mobile application software; downloadable software for use in connection with health counseling, therapy, support, and treatment; downloadable software for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; downloadable software for sending and receiving electronic messages, graphics, images, audio and audio visual content between healthcare professionals and individuals; Downloadable software for facilitating medical consultancy services; Downloadable software for providing digital health services; Downloadable software for collecting, processing, and transmitting data between health care providers and patients; Downloadable software for enabling patients to view upcoming medical procedures, prepare for office visits, request medical tests, schedule and confirm medical appointments, and receive assistance with appointment logistics; Downloadable software for use in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Downloadable software for accessing information in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Downloadable software using artificial intelligence for use in connection with health counseling, therapy, support, and treatment; Downloadable chatbot software using artificial intelligence (AI) in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Downloadable software for medical research

Software as a service (SAAS) services; Providing temporary use of online non-downloadable software; Software as a service (SAAS) services featuring software for the provision of healthcare services; Providing temporary use of online non-downloadable software for use in connection with health counseling, therapy, support, and treatment; Providing temporary use of online non-downloadable software for accessing health support services, accessing and receiving treatment, and communicating with healthcare professionals; Providing temporary use of online non-downloadable software for sending and receiving electronic messages, graphics, images, audio and audio visual content between healthcare professionals and individuals; Providing temporary use of online non-downloadable software for facilitating medical consultancy services; Providing temporary use of online non-downloadable software for providing digital health services; Providing temporary use of online non-downloadable software for collecting, processing, and transmitting data between health care providers and patients; Providing temporary use of online non-downloadable software for enabling patients to view upcoming medical procedures, prepare for office visits, request medical tests, schedule and confirm medical appointments, and receive assistance with appointment logistics; Providing temporary use of online non-downloadable software for accessing information in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software using artificial intelligence for use in connection with health counseling, therapy, support, and treatment; Providing temporary use of online non-downloadable software for use in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable chatbot software using artificial intelligence (AI) in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Providing temporary use of online non-downloadable software for medical research; Scientific and technological services and research in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications; Research and development of pharmaceuticals

Training services; Educational services; providing online non-downloadable articles, scientific papers, publications, journals, brochures, leaflets, guides, manuals, videos, and multimedia content in the fields of reproduction, early pregnancy loss, recurrent pregnancy loss, miscarriage, infertility, and pregnancy complications

Filing History

APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
May 1, 2026 XELG
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
May 1, 2026 XELR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Feb 5, 2026 GNRN
NON-FINAL ACTION E-MAILED
Feb 5, 2026 GNRT
NON-FINAL ACTION WRITTEN
Feb 5, 2026 CNRT
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 29, 2025 RCCK
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Apr 28, 2025 GNS3
LETTER OF SUSPENSION E-MAILED
Apr 28, 2025 GNSL
SUSPENSION LETTER WRITTEN
Apr 28, 2025 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Apr 15, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Apr 15, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Apr 15, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 24, 2025 GNRN
NON-FINAL ACTION E-MAILED
Mar 24, 2025 GNRT
NON-FINAL ACTION WRITTEN
Mar 24, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 23, 2025 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 11, 2024 NWOS
NEW APPLICATION ENTERED
Oct 11, 2024 NWAP